Latest filing published 05 Jan 2026 for GoodRx Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Douglas Joseph Hirsch on record concern GoodRx Holdings, Inc., in the capacity of chief executive. In total, 25 filings cover trades dated from 1 June 2021 to 1 January 2026.
No open-market purchase appears, only 4 sales worth €7.4M. The rest of the record consists of 4 share grants and 1 option exercise.
Most recently, on 5 January 2026, the filings show a share grant in GoodRx Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations